Steve Duffy, Author at Endocrinology Advisor

Steve Duffy

Digital Content Editor

All articles by Steve Duffy

Vyleesi Approved for Hypoactive Sexual Desire Disorder

Vyleesi is approved for the treatment of premenopausal women with acquired, generalized, hypoactive sexual desire disorder (HSDD) as characterized by low sexual desire that causes markeddistress or interpersonal difficulty and is not due to: a co-existing medical or psychiatric condition; problems with the relationship; or the effects of a medication or drug substance.

Next post in General Endocrinology